首页> 外文期刊>Small >Small-caliber vascular prosthesis prototype based on controlled release of heparin from mesochannels and its enhanced biocompatibility
【24h】

Small-caliber vascular prosthesis prototype based on controlled release of heparin from mesochannels and its enhanced biocompatibility

机译:小口径人工血管原型基于肝素从中通道的控释及其增强的生物相容性

获取原文
获取原文并翻译 | 示例
           

摘要

A novel small-caliber vascular prosthesis prototype is proposed on the basis of a new heparin release system, that is, the controlled delivery of heparin from mesochannels. Fabrication of mesochannels on artificial biomaterials is successfully achieved through epitaxial growth of mesoporous silica nanoparticles on expanded polytetrafluoroethylene grafts, and thus heparin can be immobilized through a space limitation effect, thereby avoiding the loss of bioactivity and enabling long-lasting release. The adsorption and release of heparin are controlled by adjusting the adsorbate-adsorbent interaction through tailoring the mesostructure. Owing to the continuous and sustained release of heparin, the performances of artificial vessels are greatly improved, thus paving a new way to prepare functional blood-contacting biomaterials with high biocompatibility.
机译:在新的肝素释放系统的基础上,提出了一种新型的小口径人工血管假体原型,即从中通道受控地输送肝素。通过在膨胀的聚四氟乙烯接枝上外延生长介孔二氧化硅纳米粒子,可以成功地在人造生物材料上制备介孔,因此可以通过空间限制作用将肝素固定化,从而避免了生物活性的丧失并可以持久释放。肝素的吸附和释放可通过调整介观结构来调节吸附物与吸附剂的相互作用来控制。由于肝素的持续释放,大大改善了人工血管的性能,从而为制备具有高生物相容性的功能性血液接触生物材料铺平了一条新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号